You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 10, March 8, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pulmonary Artery Catheter Effectiveness in Congestive Heart Failure

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial, Dr Stevenson and colleagues1 showed that the addition of the pulmonary artery catheter (PAC) to "clinical assessment alone" in the treatment of decompensated heart failure did not affect overall mortality and hospitalization. This finding of no effect could have been explained in part by use of continuous central venous pressure (CVP) monitoring via indwelling central venous lines other than PACs among participants randomized to receive therapy guided by clinical assessment alone. In the absence of pulmonary hypertension or profound right ventricular dysfunction, CVP provides a reasonable estimation of left ventricular filling characteristics.2-3 Serial measurements of CVP may provide useful information about response to treatment of volume overload.4

It would be helpful for the authors to describe the use of central lines and CVP monitoring among participants in each study group, including use . . . [Full Text of this Article]

Christine Won, MD
Division of Pulmonary and Critical Care Medicine
Stanford University Medical Center
Stanford, Calif

Ware G. Kuschner, MD
ware.kuschnermd@med.va.gov
Medical Service, Pulmonary Section
US Department of Veterans Affairs
Palo Alto Health Care System
Palo Alto, Calif



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Pulmonary Artery Catheter Effectiveness in Congestive Heart Failure—Reply
Lynne W. Stevenson, Christopher M. O’Connor, and Robert M. Califf
JAMA. 2006;295(10):1121-1122.
EXTRACT | FULL TEXT  

Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness: The ESCAPE Trial
The ESCAPE Investigators and ESCAPE Study Coordinators*
JAMA. 2005;294(13):1625-1633.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.